Abstract
Blood and urine levels of carbenicillin were measured in 10 healthy volunteers and four patients with renal failure after single and multiple oral dose of carfecillin. Urinary levels after 1000-mg doses in healthy subjects were considered sufficient for treatment of Pseudomonas aeruginosa urinary infections, but the serum levels were too low for chemotherapy of systemic infections with this organism even in severe renal failure. Urinary infections were treated in 35 inpatients with a seven-day course of carfecillin. The infection was eradicated in 21 cases (60%). In 12 cases the pathogen was Ps. aeruginosa, which was eradicated from eight patients (67%). Many patients had severe urinary tract disease. Side effects were virtually absent.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berrill W. T., Maskell R., Pead L., Polak A. Treatment of Pseudomonas urinary infections with oral carbenicillin. Br J Urol. 1973 Oct;45(5):563–567. doi: 10.1111/j.1464-410x.1973.tb06823.x. [DOI] [PubMed] [Google Scholar]
- Brumfitt W., Percival A., Leigh D. A. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967 Jun 17;1(7503):1289–1293. doi: 10.1016/s0140-6736(67)91590-5. [DOI] [PubMed] [Google Scholar]
- Eastwood J. B., Curtis J. R. Carbenicillin administration in patients with severe renal failure. Br Med J. 1968 Feb 24;1(5590):486–487. doi: 10.1136/bmj.1.5590.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gingell J. C., Waterworth P. M. Dose of gentamicin in patients with normal renal function and renal impairment. Br Med J. 1968 Apr 6;2(5596):19–22. doi: 10.1136/bmj.2.5596.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lees L. J., Harding J. W. Urinary tract infections in general practice a preliminary trial of carfecillin.. Br J Clin Pract. 1974 Oct;28(10):349–352. [PubMed] [Google Scholar]
- Meyers B. R., Sabbaj J., Weinstein L. Bacteriological, pharmacological, and clinical studies of carbenicillin. Arch Intern Med. 1970 Feb;125(2):282–286. [PubMed] [Google Scholar]
- Ries K. M., Cobbs C. G., Gillenwater J. Y., Levison M. E., Mandell G. L., Sande M. A., Kaye D. Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection. Antimicrob Agents Chemother. 1973 Dec;4(6):593–596. doi: 10.1128/aac.4.6.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace J. F., Atlas E., Bear D. M., Brown N. K., Clark H., Turck M. Evaluation of an indanyl ester of carbenicillin. Antimicrob Agents Chemother (Bethesda) 1970;10:223–226. doi: 10.1128/AAC.10.2.223. [DOI] [PubMed] [Google Scholar]